Literature DB >> 31650721

What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?

Jin Wook Kim1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31650721      PMCID： PMC6813421          DOI： 10.3346/jkms.2019.34.e277

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN： 1011-8934            Impact factor:   2.153


× No keyword cloud information.
  3 in total

1.  Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.

Authors:  Sabela Lens; Edilmar Alvarado-Tapias; Zoe Mariño; María-Carlota Londoño; Elba LLop; Javier Martinez; Jose Ignacio Fortea; Luís Ibañez; Xavier Ariza; Anna Baiges; Adolfo Gallego; Rafael Bañares; Angela Puente; Agustín Albillos; Jose Luís Calleja; Xavier Torras; Virginia Hernández-Gea; Jaume Bosch; Cándid Villanueva; Xavier Forns; Juan Carlos García-Pagán
Journal:  Gastroenterology       Date:  2017-07-20       Impact factor: 22.682

Review 2.  Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis.

Authors:  Siddharth Singh; Antonio Facciorusso; Rohit Loomba; Yngve T Falck-Ytter
Journal:  Clin Gastroenterol Hepatol       Date:  2017-05-04       Impact factor: 11.382

3.  Post-sustained Virologic Response Liver Stiffness May Underestimate Fibrosis After Direct Acting Antiviral-containing Therapy.

Authors:  Ani Kardashian; Jeff McKinney; Nina Huynh; Robin Yu; Marion Peters; Lisa Catalli; Jennifer C Price
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.